BioCentury
ARTICLE | Financial News

Theravance gains on Breo panel

April 19, 2013 12:16 AM UTC

Theravance Inc. (NASDAQ:THRX) gained $4.55 (16%) to $32.56 on Thursday after an FDA panel voted 9-4 on Wednesday that efficacy and safety data for Breo fluticasone furoate/vilanterol from partner Glax...